La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.

Identifieur interne : 000060 ( Main/Exploration ); précédent : 000059; suivant : 000061

Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.

Auteurs : Karim Selfani [Canada] ; Valérie L. Soland ; Sylvain Chouinard ; Philippe Huot

Source :

RBID : pubmed:28009769

English descriptors

Abstract

Aripiprazole is an antipsychotic that acts as a partial agonist at dopamine D2 receptors. Because of its partial agonist activity, it was believed that aripiprazole would be less susceptible than typical antipsychotics to induce extrapyramidal side effects. However, a few case-reports and case-series detailing aripiprazole-induced movement disorders have been published, suggesting that aripiprazole-induced movement disorders may arise. Here, we seek to report further cases of aripiprazole-induced movement disorders to raise the awareness of clinicians on this adverse effect.

DOI: 10.1097/NRL.0000000000000096
PubMed: 28009769


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.</title>
<author>
<name sortKey="Selfani, Karim" sort="Selfani, Karim" uniqKey="Selfani K" first="Karim" last="Selfani">Karim Selfani</name>
<affiliation wicri:level="1">
<nlm:affiliation>*Unité des Troubles du Mouvement André Barbeau †Division of Neurology, Centre Hospitalier de l'Université de Montréal Departments of ‡Neuroscience §Pharmacology, Université de Montréal ∥Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>*Unité des Troubles du Mouvement André Barbeau †Division of Neurology, Centre Hospitalier de l'Université de Montréal Departments of ‡Neuroscience §Pharmacology, Université de Montréal ∥Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, QC</wicri:regionArea>
<wicri:noRegion>QC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Soland, Valerie L" sort="Soland, Valerie L" uniqKey="Soland V" first="Valérie L" last="Soland">Valérie L. Soland</name>
</author>
<author>
<name sortKey="Chouinard, Sylvain" sort="Chouinard, Sylvain" uniqKey="Chouinard S" first="Sylvain" last="Chouinard">Sylvain Chouinard</name>
</author>
<author>
<name sortKey="Huot, Philippe" sort="Huot, Philippe" uniqKey="Huot P" first="Philippe" last="Huot">Philippe Huot</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28009769</idno>
<idno type="pmid">28009769</idno>
<idno type="doi">10.1097/NRL.0000000000000096</idno>
<idno type="wicri:Area/PubMed/Corpus">000107</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000107</idno>
<idno type="wicri:Area/PubMed/Curation">000107</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000107</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000107</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000107</idno>
<idno type="wicri:Area/Ncbi/Merge">002175</idno>
<idno type="wicri:Area/Ncbi/Curation">002175</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002175</idno>
<idno type="wicri:Area/Main/Merge">000060</idno>
<idno type="wicri:Area/Main/Curation">000060</idno>
<idno type="wicri:Area/Main/Exploration">000060</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.</title>
<author>
<name sortKey="Selfani, Karim" sort="Selfani, Karim" uniqKey="Selfani K" first="Karim" last="Selfani">Karim Selfani</name>
<affiliation wicri:level="1">
<nlm:affiliation>*Unité des Troubles du Mouvement André Barbeau †Division of Neurology, Centre Hospitalier de l'Université de Montréal Departments of ‡Neuroscience §Pharmacology, Université de Montréal ∥Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>*Unité des Troubles du Mouvement André Barbeau †Division of Neurology, Centre Hospitalier de l'Université de Montréal Departments of ‡Neuroscience §Pharmacology, Université de Montréal ∥Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, QC</wicri:regionArea>
<wicri:noRegion>QC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Soland, Valerie L" sort="Soland, Valerie L" uniqKey="Soland V" first="Valérie L" last="Soland">Valérie L. Soland</name>
</author>
<author>
<name sortKey="Chouinard, Sylvain" sort="Chouinard, Sylvain" uniqKey="Chouinard S" first="Sylvain" last="Chouinard">Sylvain Chouinard</name>
</author>
<author>
<name sortKey="Huot, Philippe" sort="Huot, Philippe" uniqKey="Huot P" first="Philippe" last="Huot">Philippe Huot</name>
</author>
</analytic>
<series>
<title level="j">The neurologist</title>
<idno type="eISSN">2331-2637</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Akathisia, Drug-Induced (etiology)</term>
<term>Antipsychotic Agents (administration & dosage)</term>
<term>Antipsychotic Agents (adverse effects)</term>
<term>Aripiprazole (administration & dosage)</term>
<term>Aripiprazole (adverse effects)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease, Secondary (chemically induced)</term>
<term>Tardive Dyskinesia (chemically induced)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Antipsychotic Agents</term>
<term>Aripiprazole</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Antipsychotic Agents</term>
<term>Aripiprazole</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en">
<term>Parkinson Disease, Secondary</term>
<term>Tardive Dyskinesia</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Akathisia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Young Adult</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Aripiprazole is an antipsychotic that acts as a partial agonist at dopamine D2 receptors. Because of its partial agonist activity, it was believed that aripiprazole would be less susceptible than typical antipsychotics to induce extrapyramidal side effects. However, a few case-reports and case-series detailing aripiprazole-induced movement disorders have been published, suggesting that aripiprazole-induced movement disorders may arise. Here, we seek to report further cases of aripiprazole-induced movement disorders to raise the awareness of clinicians on this adverse effect.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Chouinard, Sylvain" sort="Chouinard, Sylvain" uniqKey="Chouinard S" first="Sylvain" last="Chouinard">Sylvain Chouinard</name>
<name sortKey="Huot, Philippe" sort="Huot, Philippe" uniqKey="Huot P" first="Philippe" last="Huot">Philippe Huot</name>
<name sortKey="Soland, Valerie L" sort="Soland, Valerie L" uniqKey="Soland V" first="Valérie L" last="Soland">Valérie L. Soland</name>
</noCountry>
<country name="Canada">
<noRegion>
<name sortKey="Selfani, Karim" sort="Selfani, Karim" uniqKey="Selfani K" first="Karim" last="Selfani">Karim Selfani</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000060 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000060 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:28009769
   |texte=   Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:28009769" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022